Currency Exchange. All payments under this Agreement shall be payable, in full, in Dollars, regardless of the country(ies) in which sales are made. For the purposes of computing Net Sales of Licensed Products that are sold in a currency other than Dollars, such currency shall be converted into Dollars as calculated at the rate of exchange for the pertinent quarter or year to date, as the case may be, as used by Celgene in producing its quarterly and annual accounts, as confirmed by their respective auditors.
Appears in 6 contracts
Samples: Collaboration and Option Agreement (Globeimmune Inc), Collaboration and Option Agreement (Globeimmune Inc), Collaboration and Option Agreement (Globeimmune Inc)
Currency Exchange. All payments under this Agreement shall be payable, in full, in Dollars, regardless of the country(ies) in which sales are made. For the purposes of computing Net Sales of Licensed Products that are sold in a currency other than Dollars, such currency shall be converted into Dollars as calculated at the rate of exchange for the pertinent quarter or year to date, as the case may be, as used by Celgene Gilead in producing its quarterly and annual accounts, as confirmed by their respective auditors.
Appears in 4 contracts
Samples: License and Collaboration Agreement (Globeimmune Inc), License and Collaboration Agreement (Globeimmune Inc), License and Collaboration Agreement (Globeimmune Inc)
Currency Exchange. All payments under this Agreement shall be payable, in full, in Dollars, regardless of the country(ies) in which sales of the Product are made. For the purposes of computing Net Sales of Licensed Products that are sold in a currency other than Dollars, such currency shall be converted into Dollars as calculated at using the monthly average exchange rate between each currency of exchange for origin and Dollars as reported by Bloomberg or an equivalent resource as agreed by the pertinent quarter or year to date, as the case may be, as used by Celgene in producing its quarterly and annual accounts, as confirmed by their respective auditorsParties.
Appears in 3 contracts
Samples: Collaboration Agreement, Collaboration Agreement, Collaboration Agreement (Orexigen Therapeutics, Inc.)
Currency Exchange. All payments under this Agreement shall be payable, in full, in Dollars, regardless of the country(ies) in which sales are made. For the purposes of computing Net Sales of Licensed Products that are sold in a currency other than Dollars, such currency shall be converted into Dollars as calculated at using the monthly average exchange rate between each currency of exchange for origin and Dollars as reported by Bloomberg or an equivalent resource as agreed by the pertinent quarter or year to date, as the case may be, as used by Celgene in producing its quarterly and annual accounts, as confirmed by their respective auditorsParties.
Appears in 2 contracts
Samples: Collaboration Agreement (Orexigen Therapeutics, Inc.), Collaboration Agreement (Orexigen Therapeutics, Inc.)
Currency Exchange. All payments under this Agreement shall be payable, in full, in Dollars, regardless of the country(ies) in which sales are made. For the purposes of computing Net Sales of Licensed Collaboration Products Commercialized by a Party that are sold in a currency other than Dollars, such currency shall be converted into Dollars as calculated at the rate of exchange for the pertinent quarter or year to date, as the case may be, as used by Celgene in producing its quarterly and annual accounts, as confirmed by their respective auditors[***].
Appears in 2 contracts
Samples: Collaboration and Option Agreement (Fate Therapeutics Inc), Collaboration and Option Agreement (Fate Therapeutics Inc)
Currency Exchange. All payments under this Agreement shall be payable, in full, in Dollars, regardless of the country(ies) in which sales are made. For the purposes of computing Net Sales of Licensed Products or products Commercialized by OncoMed that are sold in a currency other than Dollars, such currency shall be converted into Dollars as calculated at the rate actual average rates of exchange for the pertinent quarter or year to date, as the case may be, as used by Celgene GSK or OncoMed in producing its quarterly and annual accounts, as confirmed by their respective auditors.
Appears in 1 contract
Samples: And License Agreement (OncoMed Pharmaceuticals Inc)